Rapiclav 625 is a semi-synthetic Beta-lactam antibiotic. Its main components are Amoxicillin and Clavulanic Acid with a total content of 625 mg. Rapiclav 625 is widely indicated for treating infections of the respiratory tract, urinary tract, skin, and musculoskeletal system, among others. Understanding the basic information of Rapiclav 625 will bring the best treatment effectiveness for patients.